SEC Form 4Coverage since Jul 7, 2026
$IDYA insider trading
Over the last 12 months, IDEAYA Biosciences insiders reported no purchases and 1 sale totaling $382K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $382K 1 event
- Events · 12m
- 1 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $IDYA · 12Mvia TradingView
Top insiders · 12m
Ruiz Briseno AndresChief Accounting Officer1× · $382K
All insider trades
1 event
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Ruiz Briseno AndresChief Accounting Officer · O | ▼ Sale | 9,550 | $40.01 | $382K | -26.5% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IDYA feed.